0 $0.00

Continuous Glucose Monitoring

Continuous Glucose Monitoring (CGM) is a method of tracking glucose levels in real-time, providing valuable data for individuals with diabetes to manage their condition effectively.


Want to find out more?

Thank you for trusting your family's health to a local company. Please do not hesitate to reach out with any questions you may have about CGM or the ordering process. We look forward to hearing from you!

Send Us A Message
< Back


Refer a Patient

We are eager to partner with you to support the best possible patient care.

Now, ordering for your patients is as easy as it should be. We invite you to experience the convenience firsthand. Log in to the Parachute Health to ePrescribe today!

Send Referrals via Parachute
About Our Products


Norco Medical carries:

Abbott FreeStyle Libre System

Dexcom Continuous Glucose Monitoring Systems (CGMs)



† Data from this study was collected with the outside US version of FreeStyle Libre 14 day system. FreeStyle Libre 2 has the same features as FreeStyle Libre 14 day system with optional, real-time glucose alarms. Therefore, the study data is applicable to both products.


‡ Fingersticks are required if your glucose alarms and readings do not match symptoms or when you see Check Blood Glucose symbol during the first 12 hours.


References: 1. FreeStyle Libre 2 User’s Manual. 2. Haak, Thomas, et al. “Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-treated Type 2 Diabetes: a Multicentre, Open-label Randomised Controlled Trial.” Diabetes Therapy 8, no. 1 (February 2017): 55-73. https://doi.org/10.1007/s13300-016-0223-6. 3. Al Hayek, Ayman A., Robert A. Asirvatham, and Mohamed A. Al Dawish. “Acceptability of the FreeStyle Libre Flash Glucose Monitoring System: The Experience of Young Patients With Type 1 Diabetes.” Clinical Medical Insights: Endocrinology and Diabetes 13 (March 2020): 1-7. https://doi.org/10.1177/1179551420910122. 4. Evans, Mark, et al. “The Impact of Flash Glucose Monitoring on Glycaemic Control as Measured by HbA1c: a Meta-analysis of Clinical Trials and Real-world Observational Studies.” Diabetes Therapy 11, no. 1 (January 2020): 83-95. https://doi.org/10.1007/s13300-019-00720-0.